检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中国临床新医学》2012年第3期219-221,共3页CHINESE JOURNAL OF NEW CLINICAL MEDICINE
摘 要:目的观察应用肾炎康复片联合缬沙坦治疗原发性肾病综合征(primary nephrotic syndrome,PNS)的临床效果。方法选取临床确诊为PNS患者85例,随机分为治疗组(45例)和对照组(40例)。两组除予常规降血脂、抗凝及口服缬沙坦80 mg,1次/d治疗外,治疗组还每日口服肾炎康复片2.4 g,3次/d,连续12周。检测两组治疗前后血肌酐(Scr)、白蛋白(ALB)、24 h尿蛋白定量、甘油三脂(TG)、总胆固醇(TC)及血液流变学指标。结果两组治疗后24 h尿蛋白定量、ALB、血脂及血液流变学指标均有明显改善(P<0.01),其中治疗组较对照组改善明显(P<0.05)。结论肾炎康复片能有效改善PNS患者的血液流变学,且能降低蛋白尿,提高血浆蛋白,值得临床推广应用。Objective To observe effects of shenyankangfu tablet comibined with valsartan in treatment of patients with primary nephrotic syndrome(PNS). Methods Eighty-five patients with PNS were randomly divided into control group( n = 40) and treatment group( n = 45 ). All the patients received lowering blood-lipid drugs, anticoagulation therapy and dose of valsartan was 80 mg one time per day, and the treatment group received shenyankanfu tablet on the basis of above treatment. Dose of shenyankangfu tablet was 2. 4 g three times per day. The course of treatment was 12 weeks, 24 hour urinary protein, serum creatinine, albumin, glycerin trilaurate, total cholesterol were determined before and after treatment. Results After treatment 24 h urinary protein, albumin, triglyceride, total cholesterol in two groups were ameliorated. The treatment group is superior to the control group in the amelioration of above indexes (P 〈 0. 05). Conclusion Treatments of shenyankangfu tablet comibined with valsartan in patients with PNS can ameliorated the condition of hemorbeology, reduce proteinuria and elevate serum albumin and is worth a wide clinical application.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.31